blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3082865

EP3082865 - PREVENTION AND COUNTERACTION OF DIET-INDUCED THROMBOSIS RISK [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.06.2022
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  09.07.2021
FormerGrant of patent is intended
Status updated on  09.03.2021
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
NattoPharma ASA
Lilleakerveien 2b
0283 Oslo / NO
[2021/10]
Former [2016/43]For all designated states
VitaK B.V.
Oxfordlaan 70
6229 EV Maastricht / NL
Inventor(s)01 / VERMEER, Cees
VitaK BV
Maastricht University
Oxfordlaan 70
6229 EV Maastricht / NL
 [2016/43]
Representative(s)Acapo AS
Edvard Griegs vei 1
5059 Bergen / NO
[N/P]
Former [2021/32]Acapo AS
P.O. Box 1880 Nordnes
5817 Bergen / NO
Former [2016/43]Huygens, Arthur Victor
Octrooibureau Huygens
P.O. Box 86
3400 AB IJsselstein / NL
Application number, filing date14816271.219.12.2014
[2016/43]
WO2014EP78866
Priority number, dateEP2013019896920.12.2013         Original published format: EP 13198969
[2016/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015092018
Date:25.06.2015
Language:EN
[2015/25]
Type: A1 Application with search report 
No.:EP3082865
Date:26.10.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 25.06.2015 takes the place of the publication of the European patent application.
[2016/43]
Type: B1 Patent specification 
No.:EP3082865
Date:11.08.2021
Language:EN
[2021/32]
Search report(s)International search report - published on:EP25.06.2015
ClassificationIPC:A61K31/122, A61K31/202, A61K31/455, A61K31/592, A61K31/616, A61K31/714, A61K45/06, A61P7/02, A61P9/00, A23K20/158, A23K20/174, A23L33/12, A23L33/15
[2021/13]
CPC:
A61K31/122 (EP,US); A23K20/158 (EP,US); A23K20/174 (EP,US);
A23L33/12 (EP,US); A23L33/15 (EP,US); A61K31/202 (EP,US);
A61K31/455 (EP,US); A61K31/592 (EP,US); A61K31/616 (EP,US);
A61K31/714 (EP,US); A61K45/06 (EP,US); A61P7/02 (EP);
A61P9/00 (EP) (-)
C-Set:
A61K31/122, A61K2300/00 (EP,US);
A61K31/202, A61K2300/00 (US,EP);
A61K31/455, A61K2300/00 (US,EP);
A61K31/592, A61K2300/00 (US,EP);
A61K31/616, A61K2300/00 (EP,US);
A61K31/714, A61K2300/00 (EP,US)
(-)
Former IPC [2016/43]A61K45/06, A61K31/122, A61K31/202, A61K31/455, A61K31/592, A61K31/616, A61K31/714, A61P7/02, A61P9/00, A23L33/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/43]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:PRÄVENTION UND GEGENAKTION VON DIÄTINDUZIERTER THROMBOSEGEFAHR[2021/13]
English:PREVENTION AND COUNTERACTION OF DIET-INDUCED THROMBOSIS RISK[2016/43]
French:PRÉVENTION ET ACTION CONTRAIRE DE RISQUE DE THROMBOSE INDUITE PAR LE RÉGIME ALIMENTAIRE[2021/13]
Former [2016/43]PRÄVENTION VON UND GEGENMASSNAHME BEI ERNÄHRUNGSINDUZIERTER THROMBOSEGEFAHR
Former [2016/43]PRÉVENIR ET CONTRE-CARRER UN RISQUE DE THROMBOSE INDUIT PAR UN RÉGIME ALIMENTAIRE
Entry into regional phase20.07.2016National basic fee paid 
20.07.2016Designation fee(s) paid 
20.07.2016Examination fee paid 
Examination procedure20.07.2016Examination requested  [2016/43]
08.02.2017Amendment by applicant (claims and/or description)
10.03.2021Communication of intention to grant the patent
30.06.2021Fee for grant paid
30.06.2021Fee for publishing/printing paid
30.06.2021Receipt of the translation of the claim(s)
Opposition(s)12.05.2022No opposition filed within time limit [2022/29]
Fees paidRenewal fee
02.01.2017Renewal fee patent year 03
27.12.2017Renewal fee patent year 04
01.02.2021Renewal fee patent year 05
01.02.2021Renewal fee patent year 06
01.02.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Stay/Interruption23.10.2018Interruption of proceedings. Reason: legal prevention of applicant[2019/08]
01.02.2021Resumption of proceedings[2020/50]
23.10.2018Interruption of proceedings. Reason: legal prevention of applicant[2020/50]
Lapses during opposition  TooltipAL11.08.2021
CY11.08.2021
EE11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
MK11.08.2021
MT11.08.2021
RO11.08.2021
RS11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
IS11.12.2021
LU19.12.2021
[2024/41]
Former [2024/22]AL11.08.2021
CY11.08.2021
EE11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
MK11.08.2021
RO11.08.2021
RS11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
IS11.12.2021
LU19.12.2021
Former [2023/30]AL11.08.2021
CY11.08.2021
EE11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
RO11.08.2021
RS11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
IS11.12.2021
LU19.12.2021
Former [2022/46]AL11.08.2021
EE11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
RO11.08.2021
RS11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
IS11.12.2021
LU19.12.2021
Former [2022/36]AL11.08.2021
EE11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
RO11.08.2021
RS11.08.2021
SI11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
IS11.12.2021
Former [2022/33]AL11.08.2021
EE11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
MC11.08.2021
RO11.08.2021
RS11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
IS11.12.2021
Former [2022/29]AL11.08.2021
EE11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
RO11.08.2021
RS11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
IS11.12.2021
Former [2022/26]EE11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
RO11.08.2021
RS11.08.2021
SK11.08.2021
SM11.08.2021
BG11.11.2021
IS11.12.2021
Former [2022/24]EE11.08.2021
HR11.08.2021
LT11.08.2021
LV11.08.2021
RO11.08.2021
RS11.08.2021
SK11.08.2021
BG11.11.2021
IS11.12.2021
Former [2022/10]HR11.08.2021
LT11.08.2021
LV11.08.2021
RS11.08.2021
BG11.11.2021
IS11.12.2021
Former [2022/09]LT11.08.2021
RS11.08.2021
BG11.11.2021
Former [2022/08]LT11.08.2021
BG11.11.2021
Cited inInternational search[X]US2005261257  (VERMEER CEES [NL]) [X] 1,3-15 * pages 1, 2, paragraph 12 * * page 3, paragraph 41 * * page 4, paragraphs 44, 47, 53 * * page 9; claims 1-20 * * page 5, paragraph 54 *;
 [X]WO2008006607  (NATTOPHARMA ASA [NO], et al) [X] 1,3-15 * page 14 - page 16; examples 1-8 * * page 13, line 17 - line 20 * * page 22 - page 24; claims 1-23 * * page 8, lines 32-37 - page 9, lines 1-21 * * page 17, line 6 - line 26 *;
 [X]WO2009063485  (VIRIDIS BIOPHARMA PVT LTD [IN], et al) [X] 1-15 * pages 2, 3 * * page 8, paragraphs 3rd, 4th * * page 20, paragraph 3rd * * page 33; claim 1 * * page 22 - page 27; claims 1-10 *;
 [X]WO2012161572  (FRIESLAND BRANDS BV [NL], et al) [X] 1,3-15 * pages 21, 22; claims 1-12 * * page 11, lines 15, 16 * * page 22; claim 14 * * pages 17, 18; example 1 *;
 [X]  - RONDEN J E ET AL, "Modulation of arterial thrombosis tendency in rats by vitamin K and its side chains.", ATHEROSCLEROSIS 11 JUL 1997, (19970711), vol. 132, no. 1, ISSN 0021-9150, pages 61 - 67, XP002723037 [X] 1,3-15 * page 65, column left, lines 4-6 * * page 63, column right *

DOI:   http://dx.doi.org/10.1016/S0021-9150(97)00087-7
Examination   - PINI MARIO ET AL, "Prevention of venousthromboembolism", SEMINARS IN THROMBOSIS AND HEMOSTASIS, THIEME MEDICAL PUBLISHERS, INC, US, vol. 32, no. 8, doi:10.1055/S-2006-955458, ISSN 0094-6176, (20061031), pages 755 - 766, (20061215), XP009525823

DOI:   http://dx.doi.org/10.1055/s-2006-955458
by applicantWO2008006607
    - B. DAHIBACK; B.O VILLOUTREIX, ARTERIOSCLER. THROMB. VASC. BIOL., (2005), vol. 25, pages 1311 - 1320
    - C. VERMEER; E. THEUWISSEN, MENOPAUSE INT., (2011), vol. 17, pages 19 - 23
    - E. THEUWISSEN; E. SMIT; C. VERMEER, ADV. NUTR., (2012), vol. 3, pages 166 - 173
    - C. VERMEER; M.J. SHEARER; A. ZITTERMANN; C. BOLTON-SMITH; P. SZULC,; S. HODGES,; P. WALTER; W. RAMBECK; E. STÄEKLIN; P. WEBER, EUR. J. NUTR., (2004), vol. 43, pages 1 - 11
    - SCHURGERS, L.J.; CRANENBURG, E.; VERMEER, C., THROMB. HAEMOSTAS., (2008), vol. 100, pages 593 - 596
    - RONDEN, J.E.; GROENEN-VAN DOOREN, M.M.C.L.; HORNSTRA, G.; VERMEER, C., "Modulation of arterial thrombosis tendency in rats by vitamin K and its side chains.", AFHEROSCLEROSIS, (1997), vol. 132, pages 61 - 67
    - M.J. SHEARER; X. FU; S.L. BOOTH, ADV. NUTR., (2012), vol. 3, pages 182 - 195
    - L.J. SCHURGERS; C. VERMEER, BIOCHIM. BIOPHYS. ACTA, (2002), vol. 1570, pages 27 - 32
    - E. DE SMEDT; R. AI DIERI; H.M. SPRONK; K. HAMULYAK; H. TEN CATE; H.C. HEMKER, THROMB. HAEMOST., (2008), vol. 10, pages 34 - 349
    - J.C. MCCANN; B. AMES, AM. J. CLIN. NUTR., (2009), vol. 90, pages 89 - 907
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.